ATE410679T1 - Verfahren zur identifikation von antivirale substanzen - Google Patents
Verfahren zur identifikation von antivirale substanzenInfo
- Publication number
- ATE410679T1 ATE410679T1 AT02733606T AT02733606T ATE410679T1 AT E410679 T1 ATE410679 T1 AT E410679T1 AT 02733606 T AT02733606 T AT 02733606T AT 02733606 T AT02733606 T AT 02733606T AT E410679 T1 ATE410679 T1 AT E410679T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- viruses
- life cycle
- virus
- early protein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/075—Adenoviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28954101P | 2001-05-07 | 2001-05-07 | |
| EP01201657A EP1256803A1 (de) | 2001-05-07 | 2001-05-07 | Verfahren zur Identifizierung von antiviralen Verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE410679T1 true ATE410679T1 (de) | 2008-10-15 |
Family
ID=8180262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02733606T ATE410679T1 (de) | 2001-05-07 | 2002-05-06 | Verfahren zur identifikation von antivirale substanzen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7163787B2 (de) |
| EP (2) | EP1256803A1 (de) |
| AT (1) | ATE410679T1 (de) |
| AU (1) | AU2002306089B2 (de) |
| CA (1) | CA2445911C (de) |
| DK (1) | DK1388008T3 (de) |
| NZ (1) | NZ529094A (de) |
| WO (1) | WO2002090982A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6783980B2 (en) * | 1995-06-15 | 2004-08-31 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| US7297680B2 (en) * | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
| EP1256803A1 (de) | 2001-05-07 | 2002-11-13 | Crucell Holland B.V. | Verfahren zur Identifizierung von antiviralen Verbindungen |
| EP2069483A4 (de) * | 2006-09-29 | 2010-10-27 | Sanofi Pasteur Biologics Co | Rekombinante rhinovirus-vektoren |
| EP2257308A4 (de) * | 2008-03-27 | 2012-06-27 | Sanofi Pasteur Biologics Co | Rekombinante rhinovirus-vektoren |
| SI2454364T1 (sl) * | 2009-07-16 | 2014-08-29 | Crucell Holland B.V. | Izdelava polio virusa v visokih titrih za izdelavo cepiva |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0527814B1 (de) * | 1990-04-03 | 1994-12-28 | Southwest Foundation For Biomedical Research | Immortalisierte primate hepatozyte zellinie |
| US6200745B1 (en) * | 1993-09-09 | 2001-03-13 | The Penn State Research Foundation | Vitro assay system using a human cell line for testing the effectiveness of anti-papilloma viral agents |
| IL160406A0 (en) | 1995-06-15 | 2004-07-25 | Crucell Holland Bv | A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products |
| US5939253A (en) * | 1996-04-26 | 1999-08-17 | Diagnostic Hybrids, Inc. | Compositions and methods for detecting viral infection |
| US6218105B1 (en) * | 1996-07-19 | 2001-04-17 | Kathleen S. Hall | High throughput papilloma virus in vitro infectivity assay |
| WO1999051776A1 (en) * | 1998-04-07 | 1999-10-14 | Southern Research Institute | High-throughput method for screening for antiviral activity |
| US6413776B1 (en) | 1998-06-12 | 2002-07-02 | Galapagos Geonomics N.V. | High throughput screening of gene function using adenoviral libraries for functional genomics applications |
| US20030017138A1 (en) | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
| HK1048138B (zh) * | 1999-04-15 | 2009-06-12 | 荷兰克鲁塞尔公司 | 用编码腺病毒e1蛋白的序列在人体细胞中生产重组蛋白 |
| US7527961B2 (en) * | 1999-11-26 | 2009-05-05 | Crucell Holland B.V. | Production of vaccines |
| US7521220B2 (en) * | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
| EP1103610A1 (de) | 1999-11-26 | 2001-05-30 | Introgene B.V. | Impfstoffherstellung von immortalisierten Säugetierzellinien |
| US6682892B2 (en) * | 2000-07-13 | 2004-01-27 | Pharmacia & Upjohn Company | Method for treating herpes viruses |
| EP1256803A1 (de) | 2001-05-07 | 2002-11-13 | Crucell Holland B.V. | Verfahren zur Identifizierung von antiviralen Verbindungen |
-
2001
- 2001-05-07 EP EP01201657A patent/EP1256803A1/de not_active Withdrawn
-
2002
- 2002-05-06 EP EP02733606A patent/EP1388008B1/de not_active Expired - Lifetime
- 2002-05-06 NZ NZ529094A patent/NZ529094A/en not_active IP Right Cessation
- 2002-05-06 WO PCT/NL2002/000296 patent/WO2002090982A1/en not_active Ceased
- 2002-05-06 AT AT02733606T patent/ATE410679T1/de active
- 2002-05-06 CA CA2445911A patent/CA2445911C/en not_active Expired - Lifetime
- 2002-05-06 AU AU2002306089A patent/AU2002306089B2/en not_active Ceased
- 2002-05-06 DK DK02733606T patent/DK1388008T3/da active
-
2003
- 2003-10-30 US US10/698,086 patent/US7163787B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2445911A1 (en) | 2002-11-14 |
| DK1388008T3 (da) | 2009-02-09 |
| NZ529094A (en) | 2005-07-29 |
| CA2445911C (en) | 2011-05-24 |
| EP1388008A1 (de) | 2004-02-11 |
| US7163787B2 (en) | 2007-01-16 |
| EP1256803A1 (de) | 2002-11-13 |
| AU2002306089B2 (en) | 2007-06-28 |
| EP1388008B1 (de) | 2008-10-08 |
| US20040086850A1 (en) | 2004-05-06 |
| WO2002090982A1 (en) | 2002-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0988378T4 (da) | En fremgangsmåde til in vitro molekylær udvikling af proteinfunktion | |
| DE602004030472D1 (de) | Vorrichtung und verfahren zur quantifizierung von mrna aus vollblut mit hohem durchsatz | |
| ATE431853T1 (de) | Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes | |
| DE60041355D1 (de) | Verfahren zur detektion von erkrankungen | |
| ATE416385T1 (de) | Verfahren zur quantifizierung der phosphokinaseaktivität auf proteinen | |
| ATE529744T1 (de) | Prionproteinliganden und verfahren zu ihrer verwendung | |
| DE60230927D1 (de) | Fangverbindungen, ihre entnahme und verfahren zur analysierung des proteoms und von komplexen zusammensetzungen | |
| ATE431854T1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
| Buckley | Paleoproteomics: an introduction to the analysis of ancient proteins by soft ionisation mass spectrometry | |
| DK1680681T3 (da) | Fremgangsmåde og apparat til vurdering af polypeptidaggregering | |
| ATE309540T1 (de) | Analytisches verfahren unter verwendung von multipelviren-markierung | |
| ATE462001T1 (de) | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit | |
| ATE410679T1 (de) | Verfahren zur identifikation von antivirale substanzen | |
| DE69838513D1 (de) | Verkürztes hepatitis-c-virus protein nsb5 und methoden, um antivirale substanzen zu identifizieren | |
| DE602006006855D1 (de) | Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb) | |
| ATE309544T1 (de) | Verfahren und vorrichtung zur quantifizierung von lipoprotein-cholesterol hoher dichte | |
| DK1664793T3 (da) | Neurotoksisk aminosyre eller neurotoksisk derivat deraf forbundet med neurologiske lidelser | |
| ATE545460T1 (de) | Proteomanalyseverfahren für phosphoryliertes protein | |
| ATE404692T1 (de) | Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen. | |
| ATE491938T1 (de) | Substrat für maldi-tof-ms und massenspektrometrisches verfahren unter verwendung davon | |
| ATE306659T1 (de) | Küvette für ein lesegerät zur bestimmung von substanzen mittels der evaneszenzfeldmethode | |
| MXPA01006914A (es) | Metodos para identificar combinaciones de entidades como terapeuticas. | |
| JP2006506101A5 (de) | ||
| ATE392621T1 (de) | Verfahren zur quantifizierung von glykiertem protein | |
| DE60300356D1 (de) | Ein Verfahren zur Trennung und Reinigung von RNA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1388008 Country of ref document: EP |